PLK1 and central nervous system cancer: As shown in Supplementary Figures 5D, E, patients in PLK1-high group had poorer prognosis compared to those in PLK1-low group both in chemoradiotherapy and no-chemoradiotherapy glioma patients in CGGA-325 and CGGA-693 datasets.